title: Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder.
authors.affiliation: Massachusetts General Hospital, Boston2Harvard Medical School, Boston, Massachusetts.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Fava
mesh_terms: D000701:Analgesics, Opioid / Q000378:metabolism*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D005283:Fentanyl / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D009714:Nucleus Accumbens / Q000378:metabolism*; D010919:Placebos / Q000494:pharmacology*; D049268:Positron-Emission Tomography / Q000379:methods*; D017450:Receptors, Opioid, mu / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
chemical_list: D000701:Analgesics, Opioid; D005283:Fentanyl; D010919:Placebos; D017450:Receptors, Opioid, mu; D017367:Selective Serotonin Reuptake Inhibitors